gldd posts
FeedPosted Nov 11th 2008 12:12PM by Eric Buscemi (RSS feed)
Filed under: Analyst upgrades and downgrades, Tyson Foods'A' (TSN), Analyst initiations, Urban Outfitters (URBN), KKR Financial (KFN)
.gif)
Analyst upgrades:
- Baird upgraded Optimer Pharm (NASDAQ: OPTR) to Outperform from Neutral and raised its target to $13 from $8 citing the decidedly positive data from the OPT-80 trial.
- Banc of America upgraded Quest Diagnostics (NYSE: DGX) to Buy from Neutral on valuation and believes management has set expectations well.
- Credit Suisse views Jacobs Engineering (NYSE: JEC) as a high quality name given the quality of management, execution track record, and relationship business model. Shares were upgraded to Outperform from Neutral.
- Horizon Lines (NYSE: HRZ) was upgraded to Overweight from Equal Weight at Stephens.
- Bancolombia SA (NYSE: CIB) was raised to Buy from Neutral.
- Great Lakes Dredge (NASDAQ: GLDD) was upgraded to Buy from Hold at Morgan Joseph.
Analyst downgrades:Continue reading Analyst calls: OPTR, JEC, KFN, CAR, DISH, TSN, VMW, INFY, URBN, DKS
Posted Oct 12th 2007 11:08AM by Eric Buscemi (RSS feed)
Filed under: Analyst reports, Cisco Systems (CSCO), Wal-Mart (WMT), Target Corp. (TGT), Costco Wholesale (COST), Analyst initiations
.gif)
MOST NOTEWORTHY: Encore Energy, Corporate Executive Board, FTI Consulting and Great Lakes Dredge were today's noteworthy initiations:
- Stanford believes shares of Encore Energy Partners LP (NYSE: ENP) are reasonably valued, and started shares with a Hold rating and $20.50 target.
- The Corporate Executive Board Company (NASDAQ: EXBD) was initiated with a Neutral at Baird, as they have concerns regarding the slowing economy near-term.
- Baird also started shares of FTI Consulting Inc (NYSE: FCN) with an Outperform rating and a $64 target, as they believe the company is well-positioned for continued strong growth driven by positive macro demand and specific company drivers.
- Banc of America initiated Great Lakes Dredge and Dock Corporation (NASDAQ: GLDD) with a Neutral rating and $10 target. The firm believes near-term visibility is closed by an unsettled Army Corps/domestic funding policy and is looking for a more attractive valuation.
OTHER INITIATIONS:
Posted Jul 30th 2007 9:30AM by Joseph Lazzaro (RSS feed)
Filed under: SEC filings, Other issues, Deals, Initial public offerings
Wall Street's equity market offers a solid slate this week with 7 IPOs and 4 Secondaries on the docket. Those deals tentatively scheduled to price include:
IPOs: Thursday
- Amedica (AMCA), a 4.65M-share IPO for this artificial joints company. Morgan Stanley, Goldman Sachs, and Lehman Brothers are the lead managers. Filing range: $13.00-$15.00.
- Concho Resources (CXO), a 21.2M-share IPO for this oil and gas company. JP Morgan Chase, Bank of America and Lehman Brothers are the lead managers. Filing range: $14.00-$16.00.
- Dolan Media (DM), a 10.5M-share IPO for this media services company. Goldman Sachs and Merrill Lynch are the lead managers. Filing range: $13.50-$15.50.
- Genpact (G), a 35.3M-share IPO for this information technology services company. Morgan Stanley, Citigroup, and JP Morgan Chase are the lead managers. Filing range: $16.00-$18.00.
- NanoDynamics (NDMX), a 6.6M-share IPO for this specialty chemicals company. Jefferies is the lead manager. Filing range: $12.00-$14.00.
- Sucampo Pharmaceuticals (SCMP), a 3.75M-share IPO for this pharmaceutical company. Cowen is the lead manager. Filing range: $14.00-$16.00.
- Virtusa (VRTU), a 4.4M-share IPO for this information technology services company. JP Morgan Chase is the lead manager. Filing range: $14.00-$16.00.
Continue reading IPO & secondary preview -- Week of July 30, 2007
Tesla Roadster sets a record -- travels 313 miles on a single charge
Cramer on BloggingStocks: China's industrial focus helps lots of U.S. names 
Why do we have a weak dollar?
